Nanyang Biologics, NVIDIA, HPE & Equinix to launch AI drug discovery platform
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Athena is also exploring the use of this technology for expanded carrier screening
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
For over 13 years, Star Imaging has pioneered the introduction of next-generation radiology technologies in Pune
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Subscribe To Our Newsletter & Stay Updated